Bio-Techne
TECH
#1476
Rank
A$18.87 B
Marketcap
$118.78
Share price
-1.17%
Change (1 day)
4.67%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

Bio-Techne (TECH) - Net assets

Net assets on the balance sheet as of September 2024 : A$3.37 Billion

According to Bio-Techne's latest financial reports the company has A$3.37 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Bio-Techne - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-06-30$A$2.97 B20.16%
2022-06-30$A$2.47 B18.22%
2021-06-30$A$2.09 B4.04%
2020-06-30$A$2.00 B21.09%
2019-06-30$A$1.65 B13.88%
2018-06-30$A$1.45 B17.96%
2017-06-30$A$1.23 B4.98%
2016-06-30$A$1.17 B6.64%
2015-06-30$A$1.10 B30.71%
2014-06-30$A$0.84 B4.65%
2013-06-30$A$0.80 B22.55%
2012-06-30$A$0.65 B20.13%
2011-06-30$A$0.54 B-8.09%
2010-06-30$A$0.59 B5.34%
2009-06-30$A$0.56 B11.36%
2008-06-30$A$0.50 B-1.62%
2007-06-30$A$0.51 B12.8%
2006-06-30$A$0.45 B30.53%
2005-06-30$A$0.35 B-18.48%
2004-06-30$A$0.43 B21.55%
2003-06-30$A$0.35 B-3.7%
2002-06-30$A$0.36 B5.97%
2001-06-30$A$0.34 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
A$77.48 B 2,195.79%๐Ÿ‡บ๐Ÿ‡ธ USA
A$11.81 B 250.12%๐Ÿ‡บ๐Ÿ‡ธ USA
A$40.85 B 1,110.53%๐Ÿ‡บ๐Ÿ‡ธ USA
A$80.96 B 2,298.94%๐Ÿ‡บ๐Ÿ‡ธ USA
A$5.57 B 65.06%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
A$30.14 B 793.23%๐Ÿ‡บ๐Ÿ‡ธ USA
A$88.54 M-97.38%๐Ÿ‡บ๐Ÿ‡ธ USA